IBA Group-Company profile, Business Overview, Financial Performance, Operating Segments, Strategic Moves, and Competitive Intelligence Report

Increasing count of individuals suffering with cancer and cardiac ailments foster the demand of radiopharmaceuticals market. Factors expected to boost the growth of this market are rising awareness of radiopharmaceuticals coupled with increasing use of spect & pet scans results are the. However, very short half-life of radiopharmaceuticals along with cost of capital of scanners are the factors that are expected to hamper the growth of the market. The market faces stiff competition from conventional diagnostic procedures which is a key market challenge. Potential generation of radioisotopes in the pipeline along with cancer treatment based on alpha radioimmunotherapy and Cyclotron-Based Production are the factors that is expected to create abundant growth opportunities in this market. Japanese reactors unable to suffice the domestic nuclear demand is a key threat faced by market players. Investments on discovery new radioisotopes and the use of radiopharmaceuticals and stable isotopes novel applications such as neurological applications are the winning imperatives adopted by market players to gain a stronghold of the market.